Newron Pharmaceuticals S.p.A. (SWX: NWRN)

Newron Pharmaceuticals Revenue

Newron Pharmaceuticals had revenue of 3.41M EUR in the half year ending June 30, 2024, with 20.39% growth. This brings the company's revenue in the last twelve months to 6.97M, down -20.42% year-over-year. In the year 2023, Newron Pharmaceuticals had annual revenue of 9.06M with 48.62% growth.

• Revenue (ttm): 6.97M EUR
• Revenue Growth: -20.42%
• P/S Ratio: 23.90
• Revenue / Employee: 316.82K EUR
• Employees: 22
• Market Cap: 171.43M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%
Dec 31, 2020	5.26M	-1.78M	-25.29%
Dec 31, 2019	7.04M	3.01M	74.86%